Results 101 to 110 of about 2,218 (130)

Clinical efficacy of flucytosine on urinary candidiasis [PDF]

, 1988
An antifungal agent (Flucytosine) was used to treat urinary candidiasis in 9 patients who had an indwelling catheter and developed fungal colony counts greater than 10(4).
安本, 亮二, 鶴崎, 清之, 川嶋, 秀紀, 森, 勝志, 浅川, 正純, 田中, 重人, 柿木, 宏介, 梅田, 優   +7 more
core  

Stability and bioavailability of a flucytosine suspension

, 1994
The stability and bioavailability of a suspension of flucytosine was evaluated. There was found to be no change in the flucytosine content of the suspension over a three month period.
R H Pryce-Jones, J R Johnson, D C McPhail   +2 more
core   +1 more source

Tautomerism and non-covalent interactions of flucytosine with armchair (5,5) SWCNT and γ-Fe₂O₃ nanoparticles: A DFT study

, 2017
626-632The structural parameters, energetic behavior and natural bond orbital analysis of flucytosine, as well as its tautomerization mechanism are explored theoretically using density functional theory calculations.
Beyramabadi, S Ali, Pordel, Mehdi, Mohammad-Hasani, Elham   +2 more
core  

Clinical aPDT's effect on Candida albicans: Antifungal susceptibility, virulence gene expression, and correlation with leukocyte and neutrophil counts

Photodiagnosis and Photodynamic Therapy
Background: Our previous clinical trial demonstrated that antimicrobial photodynamic therapy (aPDT) with methylene blue (MB) and potassium iodide (KI) effectively killed Candida albicans (C.
Meixia Du, Weijun Xuan, Michael R Hamblin, Liyi Huang   +3 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Caspofungin irrigation through percutaneous calicostomy catheter combined with oral flucytosine to treat fluconazole-resistant symptomatic candiduria

, 2015
International audienceCandiduria may be a marker of serious fungal infections such as pyelonephritis. With the exception of fluconazole and flucytosine, antifungals drugs are not excreted into the urine as active drugs, making the management of infection
Rondeau, E., Hennequin, Christophe, Tligui, M., Benbouzid, S., Peltier, J., Guitard, Juliette, Garcia, H., Elhaj, S. Ait   +7 more
core   +1 more source

Model‐Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic Modeling

CPT: Pharmacometrics & Systems Pharmacology
This paper presents a case study demonstrating the application of model‐informed drug development (MIDD) and early modeling integration in the development of a sustained release (SR) formulation of flucytosine for cryptococcal meningoencephalitis (CM) in
Johanna Eriksson, Erik Sjögren, Jean‐Yves Gillon, Henri Caplain, Vishal Goyal, Vijay Satam, Stephen Robinson, Isabela Ribeiro, Marylore Chenel   +8 more
doaj   +1 more source

The acquaglyceroporins CgFps1 and CgFps2 confer resistance to 5-flucytosine.

, 2015
A) Comparison, by spot assays, of the susceptibility of the C. glabrata KUE100, KUE100_Δcgfps1 and KUE100_Δcgfps2 strains (B) to 5-flucytosine, in MMB agar plates. B) Fluorescence of exponential-phase BY4741 S.
Mafalda Cavalheiro (782767), Rui Santos (490726), Catarina Costa (322963), Andreia Ponte (782765), Miguel Cacho Teixeira (782769), Hiroji Chibana (30368), Pedro Pais (782766), Takashi Yaguchi (782768)   +7 more
core   +1 more source

Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study

Drug Design, Development and Therapy, 2015
Heba F Salem,1 Sayed M Ahmed,2 Ashraf E Hassaballah,3 Mahmoud M Omar1,4 1Department of Pharmaceutics and Industrial Pharmacy, Beni-suef University, 2Department of Industrial Pharmacy, Assiut University, 3Department of Clinical Pathology, Faculty of ...
Salem HF, Ahmed SM, Hassaballah AE, Omar MM   +3 more
doaj  

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.

, 1999
Treatment failures can occur in AIDS patients infected with Cryptococcus neoformans, despite aggressive antifungal therapy. Combination regimens with additive or synergic drugs could provide additional options for treating cryptococcosis.
GIACOMETTI, Andrea, Di Francesco LF, BARCHIESI, FRANCESCO, Caselli F, Gallo D, SCALISE, Giorgio, Arzeni D   +6 more
core